BCM
MRNA icon

Boreal Capital Management’s Moderna MRNA Stock Holding History

Boreal Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Hold
100
– – 0.01% 377
2026
Q1 		$5.08K Sell
100
-300
-75% -$14K ﹤0.01% 402
2025
Q4 		$11.8K Sell
400
-100
-20% -$2.72K 0.01% 323
2025
Q3 		$12.9K Buy
500
+200
+67% +$5.58K 0.01% 323
2025
Q2 		$8.28K Buy
+300
New +$7.9K 0.01% 360

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Boreal Capital Management's MRNA Position: Q2 2026 in Review

Boreal Capital Management held its Moderna (MRNA) position steady in Q2 2026 at 100 shares worth $7K. The position accounts for 0.01% of the portfolio, ranked #377.

Boreal Capital Management first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $12.9K in Q3 2025. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Boreal Capital Management held 100 shares of Moderna worth $7K as of Q2 2026.
  • Boreal Capital Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Boreal Capital Management's portfolio in Q2 2026, its #377 holding.
  • Boreal Capital Management first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • Boreal Capital Management's Moderna position peaked at $12.9K in Q3 2025.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Boreal Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.